{"title":"Impact of Immunization in the Reduction of Mortality and Lethality Rates by COVID-19 in Brazil","authors":"Santos, Pedro Henrique Carvalho, Cruz Ytalo Gustavo Silva, Reis, Geovane Rossone, Pereira Soares, Ribeiro Mônica Cristina Siriano, Siriano Letícia Sampaio","doi":"10.24940/theijst/2022/v10/i11/st2211-006","DOIUrl":null,"url":null,"abstract":"In January 2020, a new coronavirus genetic material, Sars-CoV-2, was developed sequentially, allowing several studies to be released worldwide in search of a vaccine. In March of that year, the first vaccine was introduced and entered the human testing phase. In this scenario, this project aims to perform a correlational and comparative analysis between the immunized population of the federation units and the federal district with mortality and lethality rates by COVID-19 through statistical data treatment. The study was conducted in a statistical, retrospective study, with data available in sites linked to the Ministry of Health and the state health departments. In addition, for statistical treatment, the correlation of the data found and linear regression will be performed. Thus, all data will be gathered through data from DATASUS and the sites of each unit of the federation, covering the entire immunization period in which the country is being submitted. After data collection, they will be grouped and tabled using excel for Windows® and Word for Windows® software tools for making charts and tables. State data related to the number of immunized individuals will be compared by the students' T-test and compared using the SPSS® software. Based on the data collected, it is expected to have an overview of the impact of immunization on the reduction of COVID-19 mortality rates in all states of the country. ","PeriodicalId":153770,"journal":{"name":"The International Journal of Science & Technoledge","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of Science & Technoledge","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24940/theijst/2022/v10/i11/st2211-006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In January 2020, a new coronavirus genetic material, Sars-CoV-2, was developed sequentially, allowing several studies to be released worldwide in search of a vaccine. In March of that year, the first vaccine was introduced and entered the human testing phase. In this scenario, this project aims to perform a correlational and comparative analysis between the immunized population of the federation units and the federal district with mortality and lethality rates by COVID-19 through statistical data treatment. The study was conducted in a statistical, retrospective study, with data available in sites linked to the Ministry of Health and the state health departments. In addition, for statistical treatment, the correlation of the data found and linear regression will be performed. Thus, all data will be gathered through data from DATASUS and the sites of each unit of the federation, covering the entire immunization period in which the country is being submitted. After data collection, they will be grouped and tabled using excel for Windows® and Word for Windows® software tools for making charts and tables. State data related to the number of immunized individuals will be compared by the students' T-test and compared using the SPSS® software. Based on the data collected, it is expected to have an overview of the impact of immunization on the reduction of COVID-19 mortality rates in all states of the country.
2020年1月,一种新的冠状病毒遗传物质Sars-CoV-2相继被开发出来,从而在全球范围内发布了几项研究,以寻找疫苗。当年3月,第一种疫苗问世并进入人体试验阶段。在该场景下,本项目旨在通过统计数据处理,对联邦单位和联邦区免疫人群与COVID-19死亡率和致死率进行相关性和对比分析。这项研究是在一项统计、回顾性研究中进行的,数据来自与卫生部和州卫生部门有联系的网站。此外,为了进行统计处理,将发现的数据与线性回归进行相关性分析。因此,所有数据将通过数据库和联合会各单位站点的数据收集,涵盖该国正在提交的整个免疫期间。数据收集后,将使用excel for Windows®和Word for Windows®软件工具进行分组和制表,以制作图表和表格。与免疫个体数量相关的州数据将通过学生t检验进行比较,并使用SPSS®软件进行比较。根据所收集的数据,预计将概述免疫接种对降低该国所有州COVID-19死亡率的影响。